Trial Profile
Acute Heart Failure With High Copeptin Levels Treated With Tolvaptan Targets Increased AVP Activation for Treatment Efficacy
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Acute heart failure
- Focus Registrational; Therapeutic Use
- Acronyms ACTIVATE
- 04 Jan 2013 New trial record